These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 39379150)

  • 1. Mechanistic Insights into Tau Protein-Mediated Regulation of Oxidative Stress.
    Sethi P; C RD; Borra R; Vahora S; Vashi A; Mukherjee RK; Pavani B; Tiwari G
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2024 Oct; 40():e20240028. PubMed ID: 39379150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tau Hyperphosphorylation and Oxidative Stress, a Critical Vicious Circle in Neurodegenerative Tauopathies?
    Alavi Naini SM; Soussi-Yanicostas N
    Oxid Med Cell Longev; 2015; 2015():151979. PubMed ID: 26576216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of glob1 suppresses pathogenesis of human neuronal tauopathies in Drosophila by regulating tau phosphorylation and ROS generation.
    Nisha ; Sarkar S
    Neurochem Int; 2021 Jun; 146():105040. PubMed ID: 33865914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tau Interacting Proteins: Gaining Insight into the Roles of Tau in Health and Disease.
    Stancu IC; Ferraiolo M; Terwel D; Dewachter I
    Adv Exp Med Biol; 2019; 1184():145-166. PubMed ID: 32096036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tau pathology in Alzheimer disease and other tauopathies.
    Iqbal K; Alonso Adel C; Chen S; Chohan MO; El-Akkad E; Gong CX; Khatoon S; Li B; Liu F; Rahman A; Tanimukai H; Grundke-Iqbal I
    Biochim Biophys Acta; 2005 Jan; 1739(2-3):198-210. PubMed ID: 15615638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Tau in Various Tauopathies, Treatment Approaches, and Emerging Role of Nanotechnology in Neurodegenerative Disorders.
    Kaur P; Khera A; Alajangi HK; Sharma A; Jaiswal PK; Singh G; Barnwal RP
    Mol Neurobiol; 2023 Mar; 60(3):1690-1720. PubMed ID: 36562884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tauopathy: A common mechanism for neurodegeneration and brain aging.
    Saha P; Sen N
    Mech Ageing Dev; 2019 Mar; 178():72-79. PubMed ID: 30668956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.
    Šimić G; Babić Leko M; Wray S; Harrington C; Delalle I; Jovanov-Milošević N; Bažadona D; Buée L; de Silva R; Di Giovanni G; Wischik C; Hof PR
    Biomolecules; 2016 Jan; 6(1):6. PubMed ID: 26751493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of a truncated tau protein induces oxidative stress in a rodent model of tauopathy.
    Cente M; Filipcik P; Pevalova M; Novak M
    Eur J Neurosci; 2006 Aug; 24(4):1085-90. PubMed ID: 16930434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Ambiguous Relationship of Oxidative Stress, Tau Hyperphosphorylation, and Autophagy Dysfunction in Alzheimer's Disease.
    Liu Z; Li T; Li P; Wei N; Zhao Z; Liang H; Ji X; Chen W; Xue M; Wei J
    Oxid Med Cell Longev; 2015; 2015():352723. PubMed ID: 26171115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tau protein in familial and sporadic diseases.
    Yancopoulou D; Spillantini MG
    Neuromolecular Med; 2003; 4(1-2):37-48. PubMed ID: 14528051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tau alternative splicing in familial and sporadic tauopathies.
    Niblock M; Gallo JM
    Biochem Soc Trans; 2012 Aug; 40(4):677-80. PubMed ID: 22817715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylated tau targeted small-molecule PROTACs for the treatment of Alzheimer's disease and tauopathies.
    Jangampalli Adi P; Reddy PH
    Biochim Biophys Acta Mol Basis Dis; 2021 Aug; 1867(8):166162. PubMed ID: 33940164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinesin-1 transport reductions enhance human tau hyperphosphorylation, aggregation and neurodegeneration in animal models of tauopathies.
    Falzone TL; Gunawardena S; McCleary D; Reis GF; Goldstein LS
    Hum Mol Genet; 2010 Nov; 19(22):4399-408. PubMed ID: 20817925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial oxidative stress contributes to the pathological aggregation and accumulation of tau oligomers in Alzheimer's disease.
    Du F; Yu Q; Kanaan NM; Yan SS
    Hum Mol Genet; 2022 Aug; 31(15):2498-2507. PubMed ID: 35165721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tauopathies.
    Hernández F; Avila J
    Cell Mol Life Sci; 2007 Sep; 64(17):2219-33. PubMed ID: 17604998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic forms of tauopathies: inherited causes and implications of Alzheimer's disease-like TAU pathology in primary and secondary tauopathies.
    Langerscheidt F; Wied T; Al Kabbani MA; van Eimeren T; Wunderlich G; Zempel H
    J Neurol; 2024 Jun; 271(6):2992-3018. PubMed ID: 38554150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new non-aggregative splicing isoform of human Tau is decreased in Alzheimer's disease.
    García-Escudero V; Ruiz-Gabarre D; Gargini R; Pérez M; García E; Cuadros R; Hernández IH; Cabrera JR; García-Escudero R; Lucas JJ; Hernández F; Ávila J
    Acta Neuropathol; 2021 Jul; 142(1):159-177. PubMed ID: 33934221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frontotemporal dementia with tau pathology.
    Gasparini L; Terni B; Spillantini MG
    Neurodegener Dis; 2007; 4(2-3):236-53. PubMed ID: 17596718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular and molecular modifier pathways in tauopathies: the big picture from screening invertebrate models.
    Hannan SB; Dräger NM; Rasse TM; Voigt A; Jahn TR
    J Neurochem; 2016 Apr; 137(1):12-25. PubMed ID: 26756400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.